One study showed that administering a long-term broad-spectrum combinatorial antibiotic to APP/PS1 transgenic mice can elevate the levels of neuroinflammation and cytokines and reduce plaque-localized gliosis and alter microglial morphology, thereby exacerbating the progression of AD [64]. This evidence concerns the gene APP and Alzheimer disease.